Description
PharmaQo Tamoxifen 20 provides 20 mg Tamoxifen Citrate per oral tablet, packaged in 50-tablet packs for research use. Tamoxifen is widely studied as a selective estrogen receptor modulator (SERM), particularly in research on estrogen receptor-positive conditions, hormone regulation, and post-cycle hormone recovery models.
It’s known for its anti-estrogenic effects in breast tissue and estrogenic activity in bone and liver, making it a versatile compound for investigational endocrine studies.
Product Details:
Active Ingredient:
-
Tamoxifen Citrate
Concentration: 20 mg per tablet
Form: Oral tablets
Packaging: 50 tablets per pack
Pharmacokinetics:
Tamoxifen has an oral half-life of ~5–7 days, with active metabolites contributing to long-lasting activity.
Usage Recommendations:
-
Indications (Research Context): Investigational use in estrogen receptor modulation, hormone recovery, breast cancer models, endocrine research (not approved for human use)
-
Typical Dosage (Research Use): 10–40 mg per day, depending on study
-
Monitoring: Liver function, lipid profile, clotting factors, hormone levels
-
Cycle/Duration: As determined by research protocols
Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical risks. Always adhere to local research laws and ethical guidelines.